Zobrazeno 1 - 10
of 58
pro vyhledávání: '"NATASHA Aleksova"'
Autor:
Jennifer M. Amadio, MD, MEHP, Eduard Rodenas-Alesina, MD, Stefan Superina, MHSc, Stella Kozuszko, NP, RN, Katherine Tsang, RN, MN, Anne Simard, MHSc, Natasha Aleksova, MD, Jeremy Kobulnik, MD, MHSc, Chun-Po Steve Fan, PhD, Harindra C. Wijeysundera, MD, PhD, Heather J. Ross, MD, MHSc, Michael A. McDonald, MD, Juan G. Duero Posada, MD, MSc, Yasbanoo Moayedi, MD MHSc
Publikováno v:
CJC Open, Vol 4, Iss 5, Pp 479-487 (2022)
Background: The COVID-19 pandemic has reduced access to endomyocardial biopsy (EMB) rejection surveillance in heart transplant (HT) recipients. This study is the first in Canada to assess the role for noninvasive rejection surveillance in personalizi
Externí odkaz:
https://doaj.org/article/55dcde441b204e0496e60db8635a1890
Autor:
Natasha Aleksova, MD, Fraz Umar, MD, Jordan Bernick, MSc, Lisa M. Mielniczuk, MD MSc, Heather J. Ross, MD MSc, Sharon Chih, PhD, MBBS
Publikováno v:
CJC Open, Vol 3, Iss 12, Pp 1453-1462 (2021)
Background: Unlike the relationship with atherosclerotic coronary artery disease, that between low-density lipoprotein cholesterol (LDL-C) and cardiac allograft vasculopathy (CAV) is unclear. Our objectives were to characterize lipid profiles early a
Externí odkaz:
https://doaj.org/article/5f8232df7a104c808d9564bab3ce2dc5
Autor:
M.D. Omid Kiamanesh, Yasbanoo Moayedi, MD, Natasha Aleksova, MD, Juan Duero Posada, MD, MSc, Ariel Gershon, MD, Michael A. Seidman, MD, PhD, Vivek Rao, MD, PhD, Filio Billia, MD, PhD
Publikováno v:
CJC Open, Vol 3, Iss 2, Pp 201-203 (2021)
Patients with restrictive cardiomyopathy due to Fabry disease are often deemed ineligible for left ventricular assist device (LVAD) support due to the risk of suction events with a small LV cavity. We describe the first case series of LVAD support fo
Externí odkaz:
https://doaj.org/article/e74568a16ee34c7ab2cd76cb662329a6
Publikováno v:
Transplantation Reports, Vol 5, Iss 2, Pp - (2020)
Background: The role of antiplatelet therapy following heart transplantation (HT) is unclear. Ex-vivo studies suggest increased platelet hyperaggregability after HT. Recent studies suggest that early aspirin therapy is associated with improved surviv
Externí odkaz:
https://doaj.org/article/cea8b2ac62624de7850c769c58fbc956
Publikováno v:
CASE. 6:411-415
Autor:
Sharon Chih, Aun Yeong Chong, Vladimír Džavík, Derek Y. So, Natasha Aleksova, George A. Wells, Jordan Bernick, Christopher B. Overgaard, Ellamae Stadnick, Lisa M. Mielniczuk, Rob S.B. Beanlands, Heather J. Ross
Publikováno v:
Circulation: Heart Failure.
BACKGROUND: Early cardiac allograft vasculopathy (CAV) prognostication is needed to improve long-term outcomes after heart transplantation. We characterized first year posttransplant coronary anatomic-physiologic alterations to determine predictors o
Autor:
Mena Gewarges, Adriana Luk, Christian Pagnoux, Barbara S. Doumouras, David W. Dodington, Natasha Aleksova, Michael A. Seidman
Publikováno v:
JACC Case Reports
A patient with vascular Behçet’s syndrome (BS), a subtype of BS with mainly venous/arterial manifestations, presented with a left main aneurysm/thrombus and cardiogenic shock. The clinical diagnosis of BS includes mucocutaneous, vascular, and neur
Autor:
Sharon Chih, Natasha Aleksova
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:886-888
Autor:
Natasha Aleksova, Chun‐Po S. Fan, Farid Foroutan, Yas Moayedi, Juan Duero Posada, Caroline McGuinty, Adriana Luk, Josef Stehlik, Heather J. Ross, Ana C. Alba
Publikováno v:
Clinical Transplantation. 36
Predicted heart mass (PHM) was neither derived nor evaluated in an obese population. Our objective was to evaluate size mismatch using actual body weight or ideal body weight (IBW)-adjusted PHM on mortality and risk assessment.We conducted a retrospe
Autor:
NATASHA Aleksova, TAYLER A. BUCHAN, FARID FOROUTAN, ALICE ZHU, SEAN CONTE, PETER MACDONALD, PIERRE-EMMANUEL NOLY, MICHEL CARRIER, SILVANA F. MARASCO, KOJI TAKEDA, MATTEO POZZI, GUILLAUME BAUDRY, FERNANDO A. ATIK, SVEN LEHMANN, KHALIL JAWAD, GAVIN W. HICKEY, ANTOINE DEFONTAINE, OLIVER BARON, ANTONIO LOFORTE, GIULIO GIOVANNI CAVALLI, DANIEL O. ABSI, MASASHI KAWABORI, MICHAEL A. MASTROIANNI, MARIA SIMONENKO, SANDRO SPONGA, YASBANOO MOAYEDI, ANI ORCHANIAN-CHEFF, HEATHER J. ROSS, VIVEK RAO, GORDON GUYATT, FILIO BILLIA, ANA C. ALBA
Publikováno v:
Journal of cardiac failure.
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a prevailing option for the management of severe early graft dysfunction. This systematic review and individual patient data (IPD) meta-analysis aims to evaluate (1) mortality, (2) rates o